P8412
o-Phenylenediamine dihydrochloride
chromogenic, tablet
동의어(들):
1,2-Phenylenediamine tablet, OPD, OPD Tablet
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
Linear Formula:
C6H4(NH2)2·2HCl
CAS 번호:
Molecular Weight:
181.06
NACRES:
NA.83
PubChem Substance ID:
UNSPSC Code:
12352204
MDL number:
Beilstein/REAXYS Number:
3912045
제품 이름
o-Phenylenediamine dihydrochloride, tablet, 30 mg substrate per tablet
Quality Level
form
tablet
mp
258 °C (dec.) (lit.)
solubility
water: 1 tablet/10 mL, clear, colorless
storage temp.
2-8°C
SMILES string
Cl[H].Cl[H].Nc1ccccc1N
InChI
1S/C6H8N2.2ClH/c7-5-3-1-2-4-6(5)8;;/h1-4H,7-8H2;2*1H
InChI key
RIIWUGSYXOBDMC-UHFFFAOYSA-N
General description
o-Phenylenediamine dihydrochloride (OPD) is a chromogenic substrate that can be used in enzyme-linked immunosorbent assay (ELISA) procedures as it utilizes horseradish peroxidase conjugates. The substrate produces a soluble end product that is orange-brown and can be read spectrophotometrically at 450 nm. The OPD reaction may be stopped with 3N HCl or 3M H2SO4 and read at 492 nm.
o-Phenylenediamine dihydrochloride is a binucleophile and its condensation with α,β-unsaturated carbonyl compounds and aldehydes yields benzimidazoles.
Application
o-Phenylenediamine dihydrochloride has been used as a substrate for horse radish peroxidase in detecting:
- human immunoglobulin
- CTLA4Ig in serum samples
- albumin in culture medium
Preparation Note
Dissolve one tablet in 0.05 M phosphate-citrate buffer, pH 5.0, to the desired concentration (typically an OPD concentration of 0.4 mg/ml is used). Add 40 μl of fresh 30% hydrogen peroxide per 100 ml of substrate buffer solution, immediately prior to use. Tablets are individually packaged in foil packets.
signalword
Warning
Hazard Classifications
Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Eye Irrit. 2 - Muta. 2 - Skin Sens. 1
저장 등급
11 - Combustible Solids
wgk
WGK 3
문서
NBT-BCIP substrate system aids in western blotting and immunohistological staining, producing a blue-purple insoluble end product.
관련 콘텐츠
Asier Sáez-Cirión et al.
Nature protocols, 5(6), 1033-1041 (2010-06-12)
To advance T cell-based HIV vaccine development, it is necessary to evaluate the immune correlates of a protective CD8(+) T-cell response. We have developed an assay that assesses the capacity ex vivo of HIV-specific CD8(+) T cells to suppress HIV-1
In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations
Dhainaut F, et al.
Vox Sanguinis, 104(2), 115-126 (2013)
The reaction of o-phenylenediamine with alpha, beta-unsaturated carbonyl compounds
Claramunt RM, et al.
ARKIVOC (Gainesville, FL, United States), 14, 35-45 (2006)